YY-23

• Description :

  YY-23 is a selective inhibitor of NMDAR (containing GluN2C or GluN2D) . YY-23 inhibits GABAergic neurotransmission and enhances excitatory transmission by inhibiting NMDARs containing GluN2D on GABAergic interneurons in the prefrontal cortex. YY-23 has antidepressant activity and can be used for the research of neurological diseases[1].

• UNSPSC :

  12352005

• Target :

  IGluR

• Related Pathways :

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Purity :

  98.12

• Smiles :

  CC1=C(O[C@H]2C[C@@]3([H])[C@]4([H])CC[C@@]5(C[C@H](CC[C@@]5([C@@]4([H])CC[C@@]3([C@]21[H])C)C)O)[H])CC[C@@H](CO[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C

• Molecular Formula :

  C33H54O8

• Molecular Weight :

  578.78

• References & Citations :

  [1]Zhang J, et al. An antidepressant mechanism underlying the allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneurons. Sci Adv. 2025 Mar 7;11 (10) :eadq0444.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  NMDA Receptor

• CAS Number :

  [1365029-75-9]